Stem Cell Reality Check

Sparks, Carley
January 2013
Horse Sport;2013 Horse Health Annual, p28
The article investigates the science and science fiction of stem cell therapy. It provides a brief history of stem cell therapy beginning from the discovery of the two kinds of stem cells in bone marrows. Three types of stem cells, the embryonic stem cells, mesenchymal stem cells and induced pluripotent stem cells, are being studied by researchers. The applications of stem cells in veterinary medicine are being explored, including for tendon healing, cartilage replacement and immune modulation. INSET: Should you store cord blood?.


Related Articles

  • Stem cell therapy: A novel & futuristic treatment modality for disaster injuries. Gurudutta, G. U.; Satija, Neeraj Kumar; Singh, Vimal Kishor; Verma, Yogesh Kumar; Gupta, Pallavi; Tripathi, R. P // Indian Journal of Medical Research;Jan2012, Vol. 135 Issue 1, p15 

    Stem cell therapy hold the potential to meet the demand for transplant cells/tissues needed for treating damages resulting from both natural and man-made disasters. Pluripotency makes embryonic stem cells and induced pluripotent stem cells ideal for use, but their teratogenic character is a...

  • Senescence suppressors: their practical importance in replicative lifespan extension in stem cells. Hwang, Eun // Cellular & Molecular Life Sciences;Nov2014, Vol. 71 Issue 21, p4207 

    Recent animal and clinical studies report promising results for the therapeutic utilization of stem cells in regenerative medicine. Mesenchymal stem cells (MSCs), with their pluripotent nature, have advantages over embryonic stem cells in terms of their availability and feasibility. However,...

  • The Therapeutic Potential, Challenges and Future Clinical Directions of Stem Cells from the Wharton's Jelly of the Human Umbilical Cord. Bongso, Ariff; Fong, Chui-Yee // Stem Cell Reviews & Reports;Apr2013, Vol. 9 Issue 2, p226 

    Mesenchymal stem cells (MSCs) from bone marrow, adult organs and fetuses face the disadvantages of invasive isolation, limited cell numbers and ethical constraints while embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) face the clinical hurdles of potential immunorejection...

  • ESTOOLS Data@Hand: human stem cell gene expression resource. Kong, Lingjia; Aho, Kaisa-Leena; Granberg, Kirsi; Lund, Riikka; Järvenpää, Laura; Seppälä, Janne; Gokhale, Paul; Leinonen, Kalle; Hahne, Lauri; Mäkelä, Jarno; Laurila, Kirsti; Pukkila, Heidi; Närvä, Elisa; Yli-Harja, Olli; Andrews, Peter W; Nykter, Matti; Lahesmaa, Riitta; Roos, Christophe; Autio, Reija // Nature Methods;Sep2013, Vol. 10 Issue 9, p814 

    The article focuses on the resource ESTOOLS Data@Hand, which assists the exploration of gene expression array data in stem cell research. It mentions that ESTOOLS Data@Hand also entails stem cell pluripotency, differentiation and cell dedifferentiation. It also presents a chart illustrating...

  • Stem cells: Making fat. Baumann, Kim // Nature Reviews Molecular Cell Biology;Feb2012, Vol. 13 Issue 2, p62 

    The article discusses the differentiation of embryonic stem (ES) cells and induced pluripotent stem (iPS) cells into white and brown adipocytes. It reveals that ES and iPS cell lines were differentiated into embryoid bodies, which were then plated on culture dishes to obtain replicative...

  • Transplantation of induced pluripotent stem cell-derived renal stem cells improved acute kidney injury. Qing Li; Shou-fu Tian; Ye Guo; Xin Niu; Bin Hu; Shang-chun Guo; Nian-song Wang; Yang Wang // Cell & Bioscience;Aug2015, Vol. 5 Issue 1, p1 

    Background: Acute kidney injury (AKI) is a severe disease with high morbidity and mortality. Methods that promote repair of the injured kidney have been extensively investigated. Cell-based therapy with mesenchymal stem cells or renal progenitor cells (RPCs) resident in the kidney has appeared...

  • Characterization of novel alternative splicing variants of Oct4 gene expressed in mouse pluripotent stem cells. Liu, Xiaopeng; Yu, Tong; Sun, Yuxin; Wang, Huayan // Journal of Cellular Physiology;Jul2018, Vol. 233 Issue 7, p5468 

    Oct4 is an important transcription factor for maintaining self‐renewal and pluripotency of pluripotent stem cells (PSCs). Human OCT4 can be alternatively spliced and generate OCT4a, OCT4b, and OCT4b1. In this study, we...

  • Human iPSC and ESC translation potential debated. Fox, Jeffrey L. // Nature Biotechnology;May2011, Vol. 29 Issue 5, p375 

    The article focuses on a debate on the translation and commercialization of stem cell therapies using human induced pluripotent stem cells (iPSCs) and human embryonic stem cells (ESCs) in the U.S. It recalls a workshop held in Bethesda, Maryland in March 2011 where participants discussed the...

  • The promise of induced pluripotent stem cells in research and therapy. Robinton, Daisy A.; Daley, George Q. // Nature;1/19/2012, Vol. 481 Issue 7381, p295 

    The field of stem-cell biology has been catapulted forward by the startling development of reprogramming technology. The ability to restore pluripotency to somatic cells through the ectopic co-expression of reprogramming factors has created powerful new opportunities for modelling human diseases...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics